Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Consequences of tuberculosis among asylum seekers for health care workers in Germany.

Diel R, Loddenkemper R, Nienhaus A.

J Occup Med Toxicol. 2016 Feb 16;11:4. doi: 10.1186/s12995-016-0093-x.

2.

Mycobacterium tuberculosis epitope-specific interferon-g production in healthy Brazilians reactive and non-reactive to tuberculin skin test.

Silva BC, Grassi MF, Coutinho R, Mascarenhas RE, Olavarria VN, Coutinho-Borgo A, Kalil J, Cunha Neto E, Fonseca SG.

Mem Inst Oswaldo Cruz. 2014 Dec;109(8):999-1004. doi: 10.1590/0074-0276140193.

3.

Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.

Steffen RE, Caetano R, Pinto M, Chaves D, Ferrari R, Bastos M, de Abreu ST, Menzies D, Trajman A.

PLoS One. 2013 Apr 4;8(4):e59546. doi: 10.1371/journal.pone.0059546.

4.

How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI.

Oxlade O, Pinto M, Trajman A, Menzies D.

PLoS One. 2013;8(3):e56044. doi: 10.1371/journal.pone.0056044. Review.

5.

Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children.

Laskin BL, Goebel J, Starke JR, Schauer DP, Eckman MH.

Am J Kidney Dis. 2013 Jan;61(1):22-32. doi: 10.1053/j.ajkd.2012.06.004.

6.

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

Nienhaus A, Schablon A, Costa JT, Diel R.

BMC Health Serv Res. 2011 Sep 30;11:247. doi: 10.1186/1472-6963-11-247. Review.

7.

Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis.

Pareek M, Watson JP, Ormerod LP, Kon OM, Woltmann G, White PJ, Abubakar I, Lalvani A.

Lancet Infect Dis. 2011 Jun;11(6):435-44. doi: 10.1016/S1473-3099(11)70069-X.

8.

Recent advances in testing for latent TB.

Schluger NW, Burzynski J.

Chest. 2010 Dec;138(6):1456-63. doi: 10.1378/chest.10-0366. Review.

9.

Pairing QuantiFERON gold in-tube with opt-out HIV testing in a tuberculosis contact investigation in the Southeastern United States.

Person AK, Goswami ND, Bissette DJ, Turner DS, Baker AV, Gadkowski LB, Naggie S, Erlandson K, Chen L, Lalani T, Cox GM, Stout JE.

AIDS Patient Care STDS. 2010 Sep;24(9):539-43. doi: 10.1089/apc.2010.0102.

10.

Utilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis.

Abdalhamid B, Hinrichs SH, Garrett JL, O'Neill JM, Hansen-Cain KM, Armbrust AA, Iwen PC.

J Clin Microbiol. 2010 Aug;48(8):2955-6. doi: 10.1128/JCM.02253-09.

11.

Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.

Dyrhol-Riise AM, Gran G, Wentzel-Larsen T, Blomberg B, Haanshuus CG, Mørkve O.

BMC Infect Dis. 2010 Mar 8;10:57. doi: 10.1186/1471-2334-10-57.

12.

Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.

Pooran A, Booth H, Miller RF, Scott G, Badri M, Huggett JF, Rook G, Zumla A, Dheda K.

BMC Pulm Med. 2010 Feb 22;10:7. doi: 10.1186/1471-2466-10-7.

13.

Evaluation of the tuberculin skin test and the interferon-gamma release assay for TB screening in French healthcare workers.

Tripodi D, Brunet-Courtois B, Nael V, Audrain M, Chailleux E, Germaud P, Naudin F, Muller JY, Bourrut-Lacouture M, Durand-Perdriel MH, Gordeeff C, Guillaumin G, Houdebine M, Raffi F, Boutoille D, Biron C, Potel G, Roedlich C, Geraut C, Schablon A, Nienhaus A.

J Occup Med Toxicol. 2009 Nov 30;4:30. doi: 10.1186/1745-6673-4-30.

14.

Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive exploratory study.

Bodenmann P, Vaucher P, Wolff H, Favrat B, de Tribolet F, Masserey E, Zellweger JP.

BMC Infect Dis. 2009 Mar 24;9:34. doi: 10.1186/1471-2334-9-34.

15.
Items per page

Supplemental Content

Support Center